Kyverna Therapeutics (KYTX) EPS (Diluted) (2023 - 2026)

Kyverna Therapeutics (KYTX) EPS (Diluted) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 4.31
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 12.23
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 7.33
4 Revolution Medicines 43.64 Bn 43.64 Bn - -3.06
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.16
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 0.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.15
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 1.19
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -0.06
10 Kyverna Therapeutics 505.26 Mn 505.26 Mn - -1.16

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.16
Mar 31, 2026 -1.23
Dec 31, 2025 -0.85
Sep 30, 2025 -1.22
Jun 30, 2025 -1.02
Mar 31, 2025 -1.05
Dec 31, 2024 -1.05
Sep 30, 2024 -1.00
Jun 30, 2024 -0.96
Mar 31, 2024 -1.20
Dec 31, 2023 -30.63
Sep 30, 2023 -24.08
Jun 30, 2023 -21.73
Mar 31, 2023 -12.66